Fingerprint
Dive into the research topics of 'The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma
M. J. Overman, L. Feng, B. Pro, P. McLaughlin, M. Hess, F. Samaniego, A. Younes, J. E. Romaguera, F. B. Hagemeister, L. Kwak, F. Cabanillas, M. A. Rodriguez, L. E. Fayad*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations